| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F11-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-065 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D255-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-60 |
| filingDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3272c462ee8cb74d0a1c0d2dedafadc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b9cfc1caab092334a8223b0869cd462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a47dfcc0e6652d02b2432a7878da35e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f6913d6a082430cb1f31cb94c18a301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_723eb2662616ee2f76c63ca170baef1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecc532fe3889e8dd0d6be65be7df715 |
| publicationDate |
2004-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004138195-A1 |
| titleOfInvention |
Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f[quinoline complexes of cobalt and chromium |
| abstract |
This invention relates to a class of heterocycles and their metal complexes, and is particularly concerned with the use of these compounds in the preparation of prodrugs or as prodrugs that may be activated under hypoxic conditions by enzymes or by therapeutic ionising radiation, in the treatment of cancer. The invention also relates to the use of these heterocycles and the corresponding metal complexes in the preparation of medicaments and to compositions including the heterocycles or their metal complexes and to methods for preparing these compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016053323-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500278-B2 |
| priorityDate |
2001-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |